Skip to main content
VCbacked
Log inGet Started

Cyrano Therapeutics

Washington, United States

Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.

$9.0M raised
Jan 2024
Series B
Health CareMedicalMedical DeviceTherapeutics

Top Investors

DeepWork CapitalLumira VenturesRemiges VenturesDNV capitalFlorida Opportunity Fund

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cyrano Therapeutics

How much funding has Cyrano Therapeutics raised?
Cyrano Therapeutics has raised $9.0M in total funding. The most recent round was Series B. The last funding was announced in January 2024.
Who are Cyrano Therapeutics's investors?
Cyrano Therapeutics's investors include DeepWork Capital, Lumira Ventures, Remiges Ventures, DNV capital, Florida Opportunity Fund.
Where is Cyrano Therapeutics headquartered?
Cyrano Therapeutics is headquartered in Washington, United States.
What does Cyrano Therapeutics do?
Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.
What stage is Cyrano Therapeutics at?
Cyrano Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cyrano Therapeutics — Funding & Investors." VCBacked, January 16, 2024, https://www.vcbacked.co/company/cyrano-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2024). Cyrano Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cyrano-therapeutics
Wikipedia (cite web)
{{cite web |title=Cyrano Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cyrano-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Oryl Photonics
Lausanne
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
OncoRevive
Brunswick$119K
Circl Brain Health Metrics
Victoria$354K
YLAH
Bern$589K